1
|
Barry A, Elliott M, Loewen S, Alfieri J, Bowes D, Stuckless T, Keyes M, Debenham B, Croke J, Quartey N, Papadakos J, Giuliani M. Exploring Caregiver and Parental Roles as Radiation Oncologists in Canada. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
2
|
Corkum M, Buyyounouski M, Chang A, Chung H, Chung P, Cox B, Crook J, Davis B, Frank S, Lopez IH, Horwitz E, Hoskin P, Hsu I, Keyes M, King M, Kollmeier M, Krauss D, Kukielka A, Morton G, Orio P, Pieters B, Potters L, Rossi P, Showalter T, Solanki A, Song D, Vanneste B, Vigneault E, Wojcieszek P, Zelefsky M, Kamrava M. Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
3
|
Keyes M, Ingledew P, Loewen S, Dosani M, Tyldesley S, Brundage M, Leiter M. PO-1031 Canadian Radiation Oncology 2020 Work Engagement and Burnout Survey. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02995-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
4
|
Keyes M, MacAulay C, Guillaud M. MO-0558 Predicting Prostate Cancer Response to Brachytherapy Using AI Driven Digital Pathology. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02392-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Keyes M, Leiter M, Ingledew P, Loewen S, Tyldesley S, Dosani M, Brundage M. Canadian Radiation Oncology 2020, Work Engagement and Burnout Survey. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
6
|
Keyes M. SP-0029 This house believes: Combination therapy for intermediate and high-risk pCa represents the best standard of care. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06469-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
7
|
McKenzie AL, Athinarayanan SJ, McCue JJ, Adams RN, Keyes M, McCarter JP, Volek JS, Phinney SD, Hallberg SJ. Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study. Nutrients 2021; 13:749. [PMID: 33652715 PMCID: PMC7996820 DOI: 10.3390/nu13030749] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Revised: 02/09/2021] [Accepted: 02/19/2021] [Indexed: 02/06/2023] Open
Abstract
The purpose of this study is to assess the effects of an alternative approach to type 2 diabetes prevention. Ninety-six patients with prediabetes (age 52 (10) years; 80% female; BMI 39.2 (7.1) kg/m2) received a continuous remote care intervention focused on reducing hyperglycemia through carbohydrate restricted nutrition therapy for two years in a single arm, prospective, longitudinal pilot study. Two-year retention was 75% (72 of 96 participants). Fifty-one percent of participants (49 of 96) met carbohydrate restriction goals as assessed by blood beta-hydroxybutyrate concentrations for more than one-third of reported measurements. Estimated cumulative incidence of normoglycemia (HbA1c <5.7% without medication) and type 2 diabetes (HbA1c ≥6.5% or <6.5% with medication other than metformin) at two years were 52.3% and 3%, respectively. Prevalence of metabolic syndrome, class II or greater obesity, and suspected hepatic steatosis significantly decreased at two years. These results demonstrate the potential utility of an alternate approach to type 2 diabetes prevention, carbohydrate restricted nutrition therapy delivered through a continuous remote care model, for normalization of glycemia and improvement in related comorbidities.
Collapse
Affiliation(s)
- Amy L McKenzie
- Virta Health, San Francisco, CA 94105, USA; (S.J.A.); (R.N.A.); (J.S.V.); (S.D.P.); (S.J.H.)
| | | | - Jackson J McCue
- University of Washington School of Medicine Wyoming WWAMI, Laramie, WY 82071, USA;
| | - Rebecca N Adams
- Virta Health, San Francisco, CA 94105, USA; (S.J.A.); (R.N.A.); (J.S.V.); (S.D.P.); (S.J.H.)
| | - Monica Keyes
- Department of Bariatric and Medical Weight Loss, Indiana University Health-Arnett, Lafayette, IN 47905, USA;
| | - James P McCarter
- Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA;
- Abbott Diabetes Care, Inc., Alameda, CA 94502, USA
| | - Jeff S Volek
- Virta Health, San Francisco, CA 94105, USA; (S.J.A.); (R.N.A.); (J.S.V.); (S.D.P.); (S.J.H.)
- Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA
| | - Stephen D Phinney
- Virta Health, San Francisco, CA 94105, USA; (S.J.A.); (R.N.A.); (J.S.V.); (S.D.P.); (S.J.H.)
| | - Sarah J Hallberg
- Virta Health, San Francisco, CA 94105, USA; (S.J.A.); (R.N.A.); (J.S.V.); (S.D.P.); (S.J.H.)
- Department of Bariatric and Medical Weight Loss, Indiana University Health-Arnett, Lafayette, IN 47905, USA;
| |
Collapse
|
8
|
Oh J, Tyldesley S, Pai H, McKenzie M, Halperin R, Duncan G, Morton G, Keyes M, Hamm J, Morris W. An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2194] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Dalwadi S, Thames H, Tang C, Crook J, Sanders J, Blanchard P, Ciezki J, Keyes M, Merrick G, Catton C, Razlee H, Stock R, Sullivan F, Millar J, Frank S. Is The Phoenix Criterion Of Biochemical Failure (BF) In Men Treated With Low-Dose Rate Prostate Brachytherapy Appropriate? Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.535] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
10
|
Crook J, Tang C, Thames H, Blanchard P, Sanders J, Ciezki J, Keyes M, Merrick G, Catton C, Raziee H, Sullivan F, Stock R, Anscher M, Frank S. A Biochemical Definition of Cure Following Brachytherapy for Prostate Cancer: A Multi-Institution International Study. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.494] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
11
|
Rousseau E, Raman S, Keyes M, Krauze A, Wilson D, Bénard F. Patterns of Prostate Cancer Recurrence after Brachytherapy Imaged with PSMA-Targeting 18F-Dcfpyl PET/CT. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1863] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
12
|
Marban Orejas M, Crook J, Keyes M, Batchelar D, Dubash R, Bachand F. OC-0436 13 SCC penis treated with HDR brachytherapy, results and dosimetric analysis. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30856-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Gabr A, Keyes M, Thavarajah K, Dillon J, Cunningham N, O’Hara P, Zulkifli D, Gumani D, Murphy J, Canavan M, Costello M, Leahy A, McManus J, Lyons D, Peters C, Quinn C, Muthalvan N, ElKholy K, O’Connor M. 250Improving Care for Patients with Intracerebral Haemorrhage. Age Ageing 2018. [DOI: 10.1093/ageing/afy141.41] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Gabr
- University Hospital Limerick, Limerick, Ireland
| | - M Keyes
- University Hospital Limerick, Limerick, Ireland
| | | | - J Dillon
- University Hospital Limerick, Limerick, Ireland
| | | | - P O’Hara
- University Hospital Limerick, Limerick, Ireland
| | - D Zulkifli
- University Hospital Limerick, Limerick, Ireland
| | - D Gumani
- University Hospital Limerick, Limerick, Ireland
| | - J Murphy
- University Hospital Limerick, Limerick, Ireland
| | - M Canavan
- University Hospital Limerick, Limerick, Ireland
| | - M Costello
- University Hospital Limerick, Limerick, Ireland
| | - A Leahy
- University Hospital Limerick, Limerick, Ireland
| | - J McManus
- University Hospital Limerick, Limerick, Ireland
| | - D Lyons
- University Hospital Limerick, Limerick, Ireland
| | - C Peters
- University Hospital Limerick, Limerick, Ireland
| | - C Quinn
- University Hospital Limerick, Limerick, Ireland
| | - N Muthalvan
- University Hospital Limerick, Limerick, Ireland
| | - K ElKholy
- Tallaght University Hospital, Dublin, Ireland
| | - M O’Connor
- University of Limerick, Limerick, Ireland
| |
Collapse
|
14
|
Guillaud M, Keyes M, Ye Q, Carraro A, Harrison A, Hayes M, Nichol A, Leung S. Large-scale DNA organization is a prognostic marker of breast cancer survival. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx363.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
Keyes M, Merrick G, Frank SJ, Grimm P, Zelefsky MJ. American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review. Brachytherapy 2017; 16:245-265. [PMID: 28110898 DOI: 10.1016/j.brachy.2016.11.017] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2016] [Revised: 11/16/2016] [Accepted: 11/29/2016] [Indexed: 12/11/2022]
Abstract
PURPOSE Prostate brachytherapy (PB) has well-documented excellent long-term outcomes in all risk groups. There are significant uncertainties regarding the role of androgen deprivation therapy (ADT) with brachytherapy. The purpose of this report was to review systemically the published literature and summarize present knowledge regarding the impact of ADT on biochemical progression-free survival (bPFS), cause-specific survival (CSS), and overall survival (OS). METHODS AND MATERIALS A literature search was conducted in Medline and Embase covering the years 1996-2016. Selected were articles with >100 patients, minimum followup 3 years, defined risk stratification, and directly examining the role and impact of ADT on bPFS, CSS, and OS. The studies were grouped to reflect disease risk stratification. We also reviewed the impact of ADT on OS, cardiovascular morbidity, mortality, and on-going brachytherapy randomized controlled trials (RCTs). RESULTS Fifty-two selected studies (43,303 patients) were included in this review; 7 high-dose rate and 45 low-dose rate; 25 studies were multi-institutional and 27 single institution (retrospective review or prospective data collection) and 2 were RCTs. The studies were heterogeneous in patient population, risk categories, risk factors, followup time, and treatment administered, including ADT administration and duration (median, 3-12 months);71% of the studies reported a lack of benefit, whereas 28% showed improvement in bPFS with addition of ADT to PB. The lack of benefit was seen in low-risk and favorable intermediate-risk (IR) disease and most high-dose rate studies. A bPFS benefit of up to 15% was seen with ADT use in patients with suboptimal dosimetry, those with multiple adverse risk factors (unfavorable IR [uIR]), and most high-risk (HR) studies. Four studies reported very small benefit to CSS (2%). None of the studies showed OS advantage; however, three studies reported an absolute 5-20% OS detriment with ADT. Literature suggests that OS detriment is more likely in older patients or those with pre-existing cardiovascular disease. Four RCTs with an adequate number of patients and well-defined risk stratification are in progress. One RCT will answer the question regarding the role of ADT with PB in favorable IR patients and the other three RCTs will focus on optimal duration of ADT in the uIR and favorable HR population. CONCLUSIONS Patients treated with brachytherapy have excellent long-term disease outcomes. Existing evidence shows no benefit of adding ADT to PB in low-risk and favorable IR patients. UIR and HR patients and those with suboptimal dosimetry may have up to 15% improvement in bPFS with addition of 3-12 months of ADT, with uncertain impact on CSS and a potential detriment on OS. To minimize morbidity, one should exercise caution in prescribing ADT together with PB, in particular to older men and those with existing cardiovascular disease. Due to the retrospective nature of this evidence, significant selection, and treatment bias, no definitive conclusions are possible. RCT is urgently needed to define the potential role and optimal duration of ADT in uIR and favorable HR disease.
Collapse
Affiliation(s)
- M Keyes
- Department of Radiation Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
| | - G Merrick
- Department of Radiation Oncology, Schiffler Cancer Center, Wheeling Jesuit University, Wheeling, WV
| | - S J Frank
- Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX
| | - P Grimm
- Prostate Cancer Center of Seattle, Seattle, WA
| | - M J Zelefsky
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
| |
Collapse
|
16
|
Giambattista J, McVicar N, Martin M, Ho C, Maas B, Hay J, Wu J, Keyes M, Berthelet E. Magnitude and Timing of Gross Tumor Volume Response to Neoadjuvant Chemotherapy and Concurrent Chemoradiation in the Treatment of Locally Advanced Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2015.12.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
17
|
Giambattista J, McVicar N, Martin M, Ho C, Maas B, Hay J, Wu J, Keyes M, Berthelet E. Magnitude and Timing of GTV Response to Neoadjuvant Chemotherapy and Concurrent Chemoradiation in the Treatment of Locally Advanced Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Hamilton S, Keyes M, Moravan V, Spadinger I, Morris W. Regional Quadrant Dosimetry and Late Genitourinary Toxicity After Low-Dose-Rate Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
19
|
Rodda S, Tyldesley S, Keyes M, McKenzie M, Pai H, Duncan G, Hamm J, Morris W. Low-Dose-Rate Prostate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavorable Risk Prostate Cancer: The Results of the ASCENDE-RT Randomized Control Trial. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1038] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
20
|
Hamilton S, Tyldesley S, Hamm J, Keyes M, Pickles T, Lapointe V, Kahnamelli A, McKenzie M, Miller S, Morris W. The Incidence of Second Malignancies Following Low-Dose-Rate Brachytherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
21
|
Assana C, Feller C, Fogel M, Frelka A, Gottfried S, Jaber R, Keyes M, Koehler M, Kujawa K, Lautz N, Olson S, Pena J, Ries L, Schauer L, Scherrer C, Strandberg C, Strandberg S, Cunningham C. Kappa Opioid Receptor‐Based Treatments for Pain (LB88). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.lb88] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- C. Assana
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - C. Feller
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - M. Fogel
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - A. Frelka
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - S. Gottfried
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - R. Jaber
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - M. Keyes
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - M. Koehler
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - K. Kujawa
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - N. Lautz
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - S. Olson
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - J. Pena
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - L. Ries
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - L. Schauer
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - C. Scherrer
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - C. Strandberg
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | - S. Strandberg
- Divine Savior Holy Angels High SchoolMIlwaukeeWIUnited States
| | | |
Collapse
|
22
|
Spadinger I, Morris W, Chu J, Afsari Golshan M, Keyes M. OC-0070: Regional dose metrics and their relationship to treatment failure in I- 125 prostate brachytherapy patients. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)30175-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Keyes M, MacAulay M, Hayes M, Korbelik J, Garner D, Morris J, Palcic B. PO-171 DNA PLOIDY BASED ON ARCHIVED BIOPSY MATERIAL MAY CORRELATE WITH PSA RECURRENCE AFTER PROSTATE BRACHYTHERAPY. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)72137-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
24
|
Chan E, Keyes M, Pickles T, Lapointe V, Spadinger I, McKenzie M, Morris W. PD-123 DECLINE IN ACUTE URINARY TOXICITY: A LONG TERM STUDY IN 2011 PATIENTS WITH PROSTATE BRACHYTHERAPY. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)72090-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
25
|
Tran E, Tyldesley S, Paquette M, Hamm J, Liu M, Lim J, Keyes M, Kwan W, Pickles T. Population-based Validation of the Bolla Study in T3-4 Prostate Cancer in British Columbia. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Tam C, Spadinger I, Thomas S, Chng N, Morris W, Keyes M, Moradi M, Lobo J, Salcudean T. SU-E-T-397: Development of An Ultrasound-Based Prostate Model to Aid in CT-Based Dosimetry in Prostate Brachytherapy. Med Phys 2011. [DOI: 10.1118/1.3612351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
27
|
Abstract
Screening programmes enable health conditions to be identified so that effective interventions can be offered. The aim of this review was to determine: (1) the effectiveness of children's vision screening programmes; (2) at what age children should attend vision screening; and (3) what form vision screening programmes should take to be most effective. A literature review on the effectiveness of vision screening programmes in children aged 0-16 years was undertaken. Eligible studies/reviews were identified through clinical databases, hand searches and consultation with expert reviewers. The methodological quality of papers was rated using National Health and Medical Research Council (NHMRC) guidelines. Screening of children 18 months to 5 years, and subsequent early treatment, led to improved visual outcomes. The benefit was primarily through treatment of amblyopia, with improved visual acuity of the amblyopic eye. However, the overall quality of the evidence was low. The implication of improved visual acuity (e.g. any potential impact on quality of life) was not considered. Without consideration of 'quality of life' values, such as loss of vision in one eye or possibility of future bilateral vision loss, the cost-effectiveness of screening is questionable. Screening and treating children with uncorrected refractive error can improve educational outcomes. Evidence suggested that screening occur in the preschool years. Orthoptists were favoured as screening personnel; however, nurses could achieve high sensitivity and specificity with appropriate training. Further research is required to assess the effectiveness of neonatal screening. Most studies suggested that children's vision screening was beneficial, although programme components varied widely (e.g. tests used, screening personnel and age at testing). Research is required to clearly define any improvements to quality of life and any related economic benefits resulting from childhood vision screening. The evidence could be used to guide optimization of existing programmes.
Collapse
Affiliation(s)
- M Mathers
- Centre for Community Health, Royal Children's Hospital Murdoch Childrens Research Institute, and Western Health, Melbourne, Vic, Australia.
| | | | | |
Collapse
|
28
|
Morris W, Spadinger I, Keyes M, McKenzie M, Pickles T. CT Based Dosimetry Following Low Dose Rate (LDR) Prostate Brachytherapy in 2787 Consecutive Cases over 11 Years. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.855] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
29
|
Darud M, Giddings A, Keyes M, Tyldesley S, McGahan C. 92 EVALUATION OF A PROTOCOL TO REDUCE RECTAL VOLUME AND PROSTATE MOTION FOR EXTERNAL BEAM RADIATION THERAPY OF THE PROSTATE. Radiother Oncol 2009. [DOI: 10.1016/s0167-8140(12)72479-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
30
|
Pickles T, Morris W, Kattan M, Yu C, Keyes M. 111 PROSTATE BRACHYTHERAPY: NOMOGRAM COMPARISON WITH SURGICAL OUTCOME. Radiother Oncol 2009. [DOI: 10.1016/s0167-8140(12)72498-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
31
|
Palma D, Pickles T, Keyes M, Morris W. Reply. Urology 2009. [DOI: 10.1016/j.urology.2008.08.468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Morris WJ, Keyes M, Palma D, Spadinger I, McKenzie MR, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Berthelet E, Pai H. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Urology 2009; 73:860-5; discussion 865-7. [PMID: 19168203 DOI: 10.1016/j.urology.2008.07.064] [Citation(s) in RCA: 73] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2008] [Revised: 07/01/2008] [Accepted: 07/07/2008] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To analyze the biochemical and survival outcomes after permanent low-dose-rate prostate brachytherapy in a large, consecutive, population-based cohort of patients. METHODS A total of 1006 consecutive implants were performed from July 20, 1998 to October 23, 2003 for men with low-risk and "low-tier" intermediate-risk prostate cancer. The prescribed minimal peripheral dose was 144 Gy, using 0.33 mCi (125)I sources and a preplan technique with a strong posterior-peripheral dose bias. Most patients (65%) had received 6 months of androgen deprivation therapy. Supplemental external beam radiotherapy was not used. The prognostic features, dose metrics, and follow-up data were prospectively collected. Kaplan-Meier and Cox regression analyses were used to assess the factors associated with freedom from biochemical recurrence and survival. RESULTS The median patient age at treatment was 66 years. The median follow-up was 54 months for biochemical outcomes and 66 months for survival. The actuarial freedom from biochemical recurrence rate was 95.6% +/- 1.6% at 5 years and 94.0% +/- 2.2% at 7 years. On multivariate analysis, the pretreatment prostate-specific antigen level (P = .03) and androgen deprivation therapy use (P = .04) were predictive of the freedom from biochemical recurrence. The actuarial rates of distant metastasis and disease-specific death at 5 years were both <1%. The overall survival rate at 5 years was 95.2% +/- 1.4% and was 93.4% +/- 1.8% at 7 years. On multivariate analysis, only age was predictive of overall survival (P = .011). CONCLUSIONS When consistently planned and delivered, low-dose-rate brachytherapy, without supplemental external beam radiotherapy or intraoperative planning, can produce cancer-specific outcomes for men with low- and "low-tier" intermediate-risk prostate cancer at least equal to that produced by dose-escalated external beam radiotherapy or surgical prostatectomy.
Collapse
Affiliation(s)
- W J Morris
- British Columbia Cancer Centre, Vancouver, British Columbia, Canada.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Abstract
BACKGROUND There is increasing evidence that certain environmental factors can modify genetic effects. This is an important area of investigation as such work will help to guide the development of new intervention programs. In this paper, we address whether rural environments moderate the genetic influence on adolescent substance use and rule-breaking behavior (i.e. externalizing psychopathology). METHOD Over 1200 Minnesotan 17-year-old twins were classified as either urban or rural. Externalizing behavior was operationalized as the use and abuse of alcohol and drugs along with symptoms of conduct, oppositional defiant, and antisocial personality disorders. Biometric factor modeling estimated whether the relative contribution of genetic and shared environmental factors varied from urban to rural settings. RESULTS Residency effects reached statistical significance in the male sample only. In urban environments, externalizing behavior was substantially influenced by genetic factors, but in rural environments, shared environmental factors became more influential. This was apparent at both the individual-variable and factor levels. CONCLUSIONS These findings suggest a gene-environment interaction in the development of male adolescents' problem behaviors, including substance use. The results fit within an expanding literature demonstrating both the contextual nature of the heritability statistic and how certain environments may constrain the expression of genetic tendencies.
Collapse
Affiliation(s)
- L N Legrand
- Department of Psychology, University of Minnesota, Twin Cities Campus, Minneapolis, MN 55455, USA.
| | | | | | | | | |
Collapse
|
34
|
Miller S, Keyes M, Moravan V, Kwan W, Liu M, Morris J, Halperin R, Pai H, Pickles T. 133 Late urinary symptom flare following prostate brachytherapy. Radiother Oncol 2006. [DOI: 10.1016/s0167-8140(06)80874-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
35
|
Chung C, Keyes M, Kwa W, Weir L, Parsons C. Adjuvant axillary radiotherapy for breast cancer: Is CT planning with nodal contouring better than traditional planning? J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.606] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
606 Background: Historically, adjuvant radiotherapy planning for breast cancer has been based on clinical mark-up then subsequently bony landmarks. The objective of this study is to investigate whether individualized CT-based nodal contour guided planning of axillary fields in breast cancer improves nodal coverage and minimizes dose to normal tissues. There have been no previous studies addressing this issue. Methods: Thirty 4-field radiotherapy plans were selected as ‘traditional’ plans: 15 without nodal contours (traditional field placement) and 15 with radiation oncologists’ nodal contours. The following structures were contoured on each patient CT, regardless of previously contoured structures: level I, level II/III, supraclavicular(SCV)/infraclavicular(ICV) lymph nodes, ipsilateral brachial plexus and lung. Dose volume histograms (DVHs) of the listed contoured structures were obtained for the 30 original plans. All 30 patients were then re-planned with the same anterior dose prescription as the original plan (4000cGy/16 fractions (#) or 4500cGy/25#) but adjusted depth of midplane dose prescription based on nodal depth; MLC blocking was adjusted to the ‘study’ nodal contours. DVHs of the contoured structures for the new nodal-based plans were compared with the DVHs of the original plans, using two-tailed paired t-tests. Results: Volume receiving 90% dose (V90) was significantly improved for SCV nodes: original plan 84.67% vs nodal plan 95.76%(p=0.0005). V90 were similar for level I and level II/III nodes, but hot spots in these nodal groups were significantly hotter in the original vs nodal plan: mean hot spot for level I 120.8% vs 116.3%(p=0.0008), mean hot spot for level II/III 118.1% vs 113.2% (p=0.000003). Dose to 90% of the brachial plexus (D90) was significantly higher in the original vs nodal plan: 79.92% vs 40.92%(p=0.0028). V20 lung were not significantly different. Mean total body dose was significantly higher in the original vs nodal plan 831.8cGy vs 677.7cGy (p=0.0015). Conclusions: CT-based nodal contour guided planning significantly improves coverage of the nodes, particularly supraclavicular nodes, while markedly reducing the dose to critical normal structures, such as brachial plexus. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- C. Chung
- Vancouver Cancer Centre, Vancouver, BC, Canada
| | - M. Keyes
- Vancouver Cancer Centre, Vancouver, BC, Canada
| | - W. Kwa
- Vancouver Cancer Centre, Vancouver, BC, Canada
| | - L. Weir
- Vancouver Cancer Centre, Vancouver, BC, Canada
| | - C. Parsons
- Vancouver Cancer Centre, Vancouver, BC, Canada
| |
Collapse
|
36
|
Keyes M, MacDonald G, Krukz A, Duncan G, Moravan V, Morris W. 18 Predictive Factors for Erectile Dysfunction in Men with Prostate Cancer Following Prostate Brachytherapy: Is Dose to the Penile Bulb Important? Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80179-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Liu M, Keyes M, Pickles T, Moravan V. 128 Should we have an age limit for prostate brachytherapy? Radiother Oncol 2005. [DOI: 10.1016/s0167-8140(05)80289-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
|
39
|
Davison BJ, Keyes M, Elliott S, Berkowitz J, Goldenberg SL. Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy. BJU Int 2004; 93:965-9. [PMID: 15142144 DOI: 10.1111/j.1464-410x.2003.04761.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To identify the preferences for sexual information resources of patients before and after definitive treatment for early-stage prostate cancer with either radical prostatectomy (RP) or brachytherapy. PATIENTS AND METHODS Two hundred patients (mean age 64 years) treated with either RP or brachytherapy were recruited from radiation oncology (100) and urology (100) outpatient clinics. Patients completed a survey questionnaire to identify the types of information used, preferred sources of information, knowledge of treatments for erectile dysfunction (ED), effect of sexual function on the treatment decision, and the International Index of Erectile Function (IIEF) to assess their current level of sexual function. RESULTS Urologists were identified as the main source of sexual information. Written information, Internet access and videos were identified as preferred sources of information before and after treatment. The effects of treatment on sexual function had no apparent significant influence on the men's definitive treatment choice. Compared with patients in the brachytherapy group, patients in the RP group reported having significantly higher levels of sexual desire (P < 0.001) after treatment, but otherwise the erectile domains of the groups were remarkably similar. Two-thirds of patients wanted more information on the effects of treatment on sexual function, and on available treatments for ED. CONCLUSIONS These results support the need for physicians to offer patients access to information on the effect of treatment for early-stage prostate cancer on erectile function before and after treatment.
Collapse
Affiliation(s)
- B J Davison
- Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.
| | | | | | | | | |
Collapse
|
40
|
Liu M, Pickles T, Berthelet E, Agranovich A, Kwan W, Tyldesley S, McKenzie M, Keyes M, Morris J, Pai H. 858 Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. EJC Suppl 2003. [DOI: 10.1016/s1359-6349(03)90884-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
41
|
Liu M, Pickles T, Agranovich A, Berthelet E, Duncan G, Keyes M, Kwan W, McKenzie M, Morris J, Pai H, Tyldesley S, Wu J. Impact of neoadjuvant androgen ablation and other factors on late toxicity following external beam prostate radiation. Int J Radiat Oncol Biol Phys 2002. [DOI: 10.1016/s0360-3016(02)03513-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
42
|
Keyes M, Keane TJ, Osoba D, Duncan GG, Phillips N. Health-related quality of life in patients on radiotherapy waiting lists. Clin Oncol (R Coll Radiol) 2002; 14:329-30. [PMID: 12206647 DOI: 10.1053/clon.2002.0080] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
43
|
Blank FS, Mader TJ, Wolfe J, Keyes M, Kirschner R, Provost D. Adequacy of pain assessment and pain relief and correlation of patient satisfaction in 68 ED fast-track patients. J Emerg Nurs 2001; 27:327-34. [PMID: 11468626 DOI: 10.1067/men.2001.116648] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
INTRODUCTION The new standards of the joint commission on accreditation of healthcare organizations specify the patient's right to appropriate assessment and management of pain. With this impetus, we looked at our own practice to see how well we assess and manage patients with pain. METHODS Patients who presented with minor nonemergent pain were interviewed on arrival, and then again before discharge, with use of a structured questionnaire. A total of 68 completed pain surveys were analyzed. RESULTS With use of a visual analog scale, patients rated their pain on arrival and at discharge; they also rated pain they were willing to accept when it was time for discharge. Sixty percent of the patients went home with more pain than they were willing to accept. Fifty-one percent of the patients were offered something for pain, and only half of them said the pain relief was adequate. The median time from arrival to administration of pain medication was 104 minutes. Surprisingly, the median patient satisfaction rating for overall care was "very good." DISCUSSION This survey revealed that acute pain conditions are underevaluated and undertreated in one fast-track setting, suggesting that ED staff need more education about the management of acute pain. It also showed that relying on patient satisfaction surveys as surrogate markers for how well we manage pain is erroneous.
Collapse
Affiliation(s)
- F S Blank
- Baystate Medical Center, Springfield, MA, USA.
| | | | | | | | | | | |
Collapse
|
44
|
Abstract
PURPOSE The use of adjustable sutures in strabismus surgery has increased the rate of surgical success. Little data are available on the optimum timing for postoperative adjustment after strabismus surgery. We wanted to compare 2 common practices of adjustable suture technique after strabismus surgery. METHODS Two comparable groups of 40 patients each, who had strabismus surgery with adjustable suture technique, were prospectively studied. Group A had early adjustment the same day of the surgery about 6 hours after the operation, and group B had late adjustment the next day about 24 hours after the operation. Subjective scoring tables were used to evaluate the pain felt by the patient before, during, and after the adjustment and any difficulties of the adjustment process. Requirements of postoperative pain medications and final alignment 6 weeks after surgery were also compared. RESULTS Despite adequate statistical power, no significant differences were found between the groups regarding pain before, during, and after adjustment, difficulties performing the adjustment, and final alignment after 6 weeks (P > .05). Both adjustment schedules were equally associated with mild to moderate pain before, during, and after the adjustment. In the first 24 hours after surgery, no overall difference in the use of pain medications was found. Nausea and vomiting in the first 24 postoperative hours were more common in the early adjustment group (P = .02). CONCLUSION The surgeon can feel free to choose the timing for postoperative adjustment. However, when performing an early adjustment, the surgeon should be especially prepared to control nausea and vomiting.
Collapse
Affiliation(s)
- F G Velez
- Department of Ophthalmology and Anesthesiology, University of California, Los Angeles, California 90095, USA
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Affiliation(s)
- F S Blank
- Emergency Department, Baystate Medical Center, Springfield, Mass., USA
| | | |
Collapse
|
46
|
Blank FS, Doe S, Keyes M, Labrie L, Sabourin D, Patel S. Development of an ED teaching program aimed at reducing prehospital delays for patients with chest pain. J Emerg Nurs 1998; 24:316-9. [PMID: 9814234 DOI: 10.1016/s0099-1767(98)90103-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
OBJECTIVE Delays in providing thrombolytic agents to patients with chest pain occur mainly in the prehospital arena. To reduce prehospital delay in treating patients with chest pain, we created a discharge teaching video that emphasized calling 911 in the event of a possible heart attack and a written action plan to be posted near the telephone. We also gave patients their EKG readings to bring with them on their next visit to the emergency department. SETTING AND SAMPLE All patients with chest pain admitted to the Chest Pain Observation Unit at Baystate Medical Center, Springfield, Mass, were eligible for this teaching effort. We tracked 127 nonconsecutive patients from January 1997 to May 1997. Of these patients, 108 were included in the study. RESULTS We interviewed 102 patients (94%) 3 days after they were discharged from the Chest Pain Observation Unit. Within this group, 92% were able to describe what a heart attack might feel like, and 81.4% said they would call 911 or go to the hospital if they had symptoms of a heart attack. If they thought that their symptoms might be indigestion, 69% said they would take an antacid, then go to the hospital if they did not feel better. Fifty-one percent remembered what to do with their EKG readings, and 60.7% knew how to take their nitroglycerin correctly. CONCLUSION We concluded that patients understood the message they were given and retained some of the material 3 days after discharge from the Chest Pain Observation Unit. The follow-up telephone calls revealed areas for improvement in the discharge teaching tools.
Collapse
Affiliation(s)
- F S Blank
- Baystate Medical Center, Springfield, Mass., USA
| | | | | | | | | | | |
Collapse
|
47
|
Keyes M. Homosexuality: struggling with a hard issue. J Christ Nurs 1998; 15:18-22. [PMID: 9464020 DOI: 10.1097/00005217-199815010-00009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
|
48
|
Keyes M. Can Christianity & feminism agree? Christ Nurse Int 1997; 12:10-5. [PMID: 9355315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
49
|
Abstract
Evidence from a variety of studies suggests that many mammalian muscles are partitioned with respect to their architecture and innervation. Each of these specific muscle subvolumes is innervated by an individual muscle nerve branch, contains motor unit territories with a unique array of physiological attributes and has been known as a neuromuscular compartment or segment. This gross anatomic study investigated for evidence of neuromuscular segmentation in human fibularis (peroneus) longus and brevis muscles. Forty-three legs (24 left, 19 right) from embalmed adult cadavers were dissected. Any architectural segment within these muscles were identified. The specific innervation patterns of these muscles were also described. The fibularis longus muscle was consistently found to have connective tissue partitions that separated it into four parts: anterior superficial, anterior deep, posterior superficial, and posterior deep. The innervation pattern of this muscle was consistent with the segments defined by the connective tissue partitions. There were consistently four primary motor branches, each supplying a specific portion of the fibularis longus muscle. While a typical branching pattern was recognized, there was some variability as to the order of these branches as they originated. The fibularis brevis muscle was consistently found to have a central connective tissue partition that separated it into two portions: anterior and posterior. In 91% of the fibularis brevis muscles, there were two primary motor branches, one for each of the two segments of the muscle. In the other 9%, only one primary motor branch supplying the muscle could be identified.
Collapse
Affiliation(s)
- B W Bakkum
- National College of Chiropractic, Lombard, Illinois, USA
| | | | | | | |
Collapse
|
50
|
Blank FS, Austin M, Bennett A, Doe S, Gregory A, Keyes M, Labrie L, Loughlin L, Sabourin D, Vezolla R. Decreasing "door to thrombolysis" time at one busy acute care hospital. J Emerg Nurs 1995; 21:202-7. [PMID: 7630052 DOI: 10.1016/s0099-1767(05)80152-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|